首页> 外国专利> Palonosetron clearing pharmaceutical formula

Palonosetron clearing pharmaceutical formula

机译:帕洛诺司琼清除药物配方

摘要

It refers to the dissolution formula of isoquinol compound (3a) - 2, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 4, 5, 6-hexahydro-1-oxo-1h-benzo (DE), which is called palonosetron. It is characterized by stability before long-term storage and allows the use of a concentration lower than the possible concentration. It is generally expected to be characterised by the presence of palonosetron hydrochloride in the range of about 0.01 mg / ml to 5 mg / ml, as well as a vehicle acceptable in a pH range of about 4.0-6.0 and in a cell acid-base reducing solution of about 10-100 ml,And about 0.005 to 1.0 mg / ml of amphetamine type stimulants. Adding Manitoba and a coagulant can improve the stability of the formula. They are useful tools to reduce spasticity caused by chemotherapy and radiotherapy, and are formulated for injection and oral liquid drug preparation.
机译:指异喹啉化合物(3a)的溶出式-2、3、3、3、3、3、3、3、3、3、3、3、3、3、4、5、6-六氢-1 -oxo-1h-苯并(DE),称为帕洛诺司琼。它的特点是在长期储存之前具有稳定性,并允许使用低于可能浓度的浓度。通常预期其特征在于存在帕洛诺司琼盐酸盐的范围为约0.01 mg / ml至5 mg / ml,以及在约4.0-6.0的pH范围内和在细胞酸碱中可接受的媒介物还原溶液约10-100毫升,以及约0.005至1.0毫克/毫升的苯丙胺类兴奋剂。添加马尼托巴和混凝剂可以改善配方的稳定性。它们是减少化学疗法和放射疗法引起的痉挛的有用工具,被配制用于注射和口服液体药物的制备。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号